Skip to main content

Table 2 Clinical characteristics and outcomes in intervention group and control group patients

From: Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study

  Intervention group Control group T-value Sig.
Mean (S.D.) Mean (S.D.)
General overuse 12.42 (2.24) 12.74 (2.63) 0.966 0.335
General harm 11.16 (2.50) 10.88 (2.96) 0.763 0.446
Beneficial effect of pharmaceuticals 14.69 (1.97) 14.96 (2.14) 0.984 0.326
Beliefs about medicines 38.27 (3.92) 38.58 (4.48) 0.545 0.587
Sensitive 15.72 (2.66) 15.55 (3.13) 0.441 0.660
Necessity beliefs 18.19 (3.68) 18.30 (4.19) 0.205 0.838
Concern beliefs 13.07 (3.36) 13.38 (4.04) 0.616 0.538
Treatment Satisfaction Questionnaire for Medication (TSQM) 83.20 (11.42) 82.54 (13.41) 0.396 0.692
Estimated weights for EQ-5D 0.63 (0.37) 0.65 (0.38) 0.414 0.680
Montgomery–Åsberg Depression Scale 22.90 (13.27) 21.44 (12.89) 0.830 0.408
Medication Adherence Scale 5.13 (1.80) 5.19 (2.05) 0.218 0.827
  1. T-test for the difference in the characteristics of the study, according to the level of adherence